347 related articles for article (PubMed ID: 22211772)
41. Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.
Josiassen RC; Shaughnessy RA; Filymer DM; Donohue AM; Kacso M; Finkel N; Curtis J; Audino B; Skuban N
Early Interv Psychiatry; 2010 Feb; 4(1):57-63. PubMed ID: 20199481
[TBL] [Abstract][Full Text] [Related]
42. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD
Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
[TBL] [Abstract][Full Text] [Related]
43. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
[TBL] [Abstract][Full Text] [Related]
44. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
45. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
[TBL] [Abstract][Full Text] [Related]
46. Treatment-emergent psychosis with aripiprazole.
Barnas ME; Hussain N; Petrides G
J Clin Psychiatry; 2005 Oct; 66(10):1339. PubMed ID: 16259556
[No Abstract] [Full Text] [Related]
47. Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol.
de Oliveira IR; Elkis H; Gattaz WF; Chaves A; de Sena EP; de Matos E Souza FG; Campos JA; Bueno JR; E Silva JA; Louzã MR; de Abreu PB
CNS Spectr; 2009 Feb; 14(2):93-102. PubMed ID: 19238124
[TBL] [Abstract][Full Text] [Related]
48. Clozapine-induced hyperlipidemia resolved after switch to aripiprazole therapy.
Ball MP; Hooper ET; Skipwith DF; Cates ME
Ann Pharmacother; 2005 Sep; 39(9):1570-2. PubMed ID: 16046490
[TBL] [Abstract][Full Text] [Related]
49. Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis.
Farnia V; Shakeri J; Tatari F; Juibari TA; Yazdchi K; Bajoghli H; Brand S; Abdoli N; Aghaei A
Am J Drug Alcohol Abuse; 2014 Jan; 40(1):10-5. PubMed ID: 24359506
[TBL] [Abstract][Full Text] [Related]
50. Central sleep apnea in a geriatric patient treated with aripiprazole.
Kohen I; Sarcevic A
Am J Ther; 2009; 16(2):197-8. PubMed ID: 19300045
[TBL] [Abstract][Full Text] [Related]
51. Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.
Apiquian R; Fresán A; Herrera K; Ulloa RE; Lóyzaga C; de la Fuente-Sandoval C; Gutiérrez D; Nicolini H
Int J Neuropsychopharmacol; 2003 Dec; 6(4):403-8. PubMed ID: 14604455
[TBL] [Abstract][Full Text] [Related]
52. Hyperprolactinaemia on depot risperidone treated with aripiprazole.
Anandarajan T; Tibrewal P; Dhillon R; Bastiampillai T
Aust N Z J Psychiatry; 2012 Aug; 46(8):792-3. PubMed ID: 22528973
[No Abstract] [Full Text] [Related]
53. Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.
Leo R; Razzini C; Di Lorenzo G; Bianchi F; Tesauro M; Zanasi M; Siracusano A; Romeo F
J Clin Psychiatry; 2008 Feb; 69(2):327-8. PubMed ID: 18363460
[No Abstract] [Full Text] [Related]
54. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.
Hirose T; Uwahodo Y; Yamada S; Miwa T; Kikuchi T; Kitagawa H; Burris KD; Altar CA; Nabeshima T
J Psychopharmacol; 2004 Sep; 18(3):375-83. PubMed ID: 15358981
[TBL] [Abstract][Full Text] [Related]
55. Reversible Pisa syndrome associated with switching from haloperidol to aripiprazole during lithium treatment.
Huang YC; Lee Y; Lin PY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1284-5. PubMed ID: 19635518
[No Abstract] [Full Text] [Related]
56. Efficacy of high-dose aripiprazole for treatment-resistant schizoaffective disorder: a case report.
Saatcioglu O; Gumus S; Kamberyan K; Yanik M
Psychopharmacol Bull; 2010; 43(4):70-2. PubMed ID: 21240152
[TBL] [Abstract][Full Text] [Related]
57. [The use of atypical antipsychotics in the long-term care of schizophrenia].
Limosin F
Encephale; 2006 Dec; 32 Pt 3():S1065-71. PubMed ID: 17356501
[No Abstract] [Full Text] [Related]
58. Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department.
Wilson MP; Minassian A; Bahramzi M; Campillo A; Vilke GM
J Emerg Med; 2014 Jun; 46(6):808-13. PubMed ID: 24656982
[TBL] [Abstract][Full Text] [Related]
59. Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine.
Strack DK; Leckband SG; Meyer JM
J Psychiatr Pract; 2009 Nov; 15(6):442-8. PubMed ID: 19934718
[TBL] [Abstract][Full Text] [Related]
60. Current evidence for aripiprazole as augmentation therapy in major depressive disorder.
Khan A
Expert Rev Neurother; 2008 Oct; 8(10):1435-47. PubMed ID: 18928339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
